Tirzepatide titration may continue as follows: Week 8: 7.5 mg weekly (if 5 mg was well-tolerated) Week 12: 10 mg weekly (for patients who need additional appetite suppression) Week 16: Up to 12.5 mg or 15 mg (maximum doses, used selectively) Ipamorelin adjustments: If well-tolerated at 200 mcg, may increase to 250 to 300 mcg daily Some physicians add a second daily dose (morning, fasted) for enhanced GH support If water retention or joint stiffness develops, dose may be reduced Labs at the 8-week mark should include IGF-1, thorough metabolic panel, HbA1c, and lipids
Yes, some patients report increased anxiety, though data is limited and varies by individual
GLP-1 weight-loss drug use surges across Australia amid safety warnings and supply shortages, NewsWire
The benzyl alcohol preservative has been associated with serious adverse eventsincluding fatal gasping syndrome when used in pediatric or vulnerable populations
Patients should also be encouraged to drink plenty of fluids and eat a well-balanced diet when beginning treatment
The patient who needs rapid, clinically significant weight loss for diabetes management is not the same patient as the one who wants to reduce visceral fat while preserving the lean mass they have built over years of training
